English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 22 Help

Selected(0)Clear Items/Page:    Sort:
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 Journal article
Lau, George, Obi, Shuntaro, Zhou, Jian, Tateishi, Ryosuke, Qin, Shukui, Zhao, Haitao, Otsuka, Motoyuki, Ogasawara, Sadahisa, George, Jacob, Chow, Pierce K.H., Cai, Jianqiang, Shiina, Shuichiro, Kato, Naoya, Yokosuka, Osamu, Oura, Kyoko, Yau, Thomas, Chan, Stephen L., Kuang, Ming, Ueno, Yoshiyuki, Chen, Minshan, Cheng, Ann Lii, Cheng, Gregory, Chuang, Wan Long, Baatarkhuu, Oidov, Bi, Feng, Dan, Yock Young, Gani, Rino A., Tanaka, Atsushi, Jafri, Wasim, Jia, Ji Dong, Kao, Jia Horng, Hasegawa, Kiyoshi, Lau, Patrick, Lee, Jeong Min, Liang, Jun, Liu, Zhenwen, Lu, Yinying, Pan, Hongming, Payawal, Diana A., Rahman, Salimur, Seong, Jinsil, Shen, Feng, Shiha, Gamal, Song, Tianqiang, Sun, Hui Chuan, Masaki, Tsutomu, Sirachainan, Ekaphop, Wei, Lai, Yang, Jin Mo, Sallano, Jose D., Zhang, Yanqiao, Tanwandee, Tawesak, Dokmeci, AKadir, Zheng, Shu Sen, fan, Jia, Fan, Sheung Tat, Sarin, Shiv Kumar, Omata, Masao. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024[J]. Hepatology International, 2024, 18(6), 1661-1683.
Authors:  Lau, George;  Obi, Shuntaro;  Zhou, Jian;  Tateishi, Ryosuke;  Qin, Shukui; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.9/6.6 | Submit date：2024/12/05
Hepatocellular Carcinoma  Systemic Therapy  Guidelines  The Asian Pacific Association For The Study Of The Liver  
Antagonizing pathological α-synuclein-mediated neurodegeneration by J24335 via the activation of immunoproteasome Journal article
Pan, Zhijian, Yu, Chao Wu, Zhao, Chen, Shao, Min, Yang, Xuanjun, Liang, Xiaonan, Li, Haitao, Lu, Yucong, Ye, Qingqing, Chern, Ji Wang, Lu, Jiahong, Zhou, Hefeng, Lee, Simon Ming Yuen. Antagonizing pathological α-synuclein-mediated neurodegeneration by J24335 via the activation of immunoproteasome[J]. Toxicology and Applied Pharmacology, 2023, 480, 116745.
Authors:  Pan, Zhijian;  Yu, Chao Wu;  Zhao, Chen;  Shao, Min;  Yang, Xuanjun; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:3.3/3.6 | Submit date：2024/01/02
Immunoproteasome  J24335  Lmp7  Parkinson's Disease  Protein Degradation  Α-synuclein  
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy Journal article
Meng, Jialin, Jiang, Aimin, Lu, Xiaofan, Gu, Di, Ge, Qintao, Bai, Suwen, Zhou, Yundong, Zhou, Jun, Hao, Zongyao, Yan, Fangrong, Wang, Linhui, Wang, Haitao, Du, Juan, Liang, Chaozhao. Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy[J]. iMeta, 2023, 2(4), e147.
Authors:  Meng, Jialin;  Jiang, Aimin;  Lu, Xiaofan;  Gu, Di;  Ge, Qintao; et al.
Favorite | TC[WOS]:11 TC[Scopus]:13  IF:23.7/23.7 | Submit date：2024/01/10
Clear Cell Renal Cell Carcinoma  Immune Activation  Molecular Subtyping  Multiomics  
TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies Journal article
Jialin Meng, Jingjing Gao, Xiao Li, Rui Gao, Xiaofan Lu, Jun Zhou, Fangrong Yan, Haitao Wang, Yi Liu, Zongyao Hao, Xiansheng Zhang, Chaozhao Liang. TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies[J]. Cellular Oncology, 2023, 46(3), 745-759.
Authors:  Jialin Meng;  Jingjing Gao;  Xiao Li;  Rui Gao;  Xiaofan Lu; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:4.9/5.2 | Submit date：2023/07/27
Fscn1  Immune-exhausted  Molecular Subtype  Testicular Germ Cell Tumor  
Editorial: Epigenetics of metabolism, immunology and aging Other
2023-01-18
Authors:  Zeng,Hailuan;  Lu,Xiaofan;  Sun,Heng;  Wang,Haitao
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2023/08/03
Methylation  Histone Modification  Metabolism  Cancer  Epigenetic Age  Immune  
Emerging pharmacotherapy for inflammatory bowel diseases Review article
2022
Authors:  Hua Luo;  Guiqing Cao;  Chun Luo;  Dechao Tan;  Chi Teng Vong ; et al.
Favorite | TC[WOS]:53 TC[Scopus]:59  IF:9.1/9.0 | Submit date：2022/05/04
Emerging Pharmacotherapy  Ibd  Molecular Pathogenesis  Therapeutic Targets  
Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific smad4/pten mutant mice Journal article
Zhao, Ming, Quan, Yingyao, Zeng, Jianming, Lyu, Xueying, Wang, Haitao, Lei, Josh Haipeng, Feng, Yangyang, Xu, Jun, Chen, Qiang, Sun, Heng, Xu, Xiaoling, Lu, Ligong, Deng, Chu Xia. Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific smad4/pten mutant mice[J]. International Journal of Biological Sciences, 2021, 17(15), 4176-4191.
Authors:  Zhao, Ming;  Quan, Yingyao;  Zeng, Jianming;  Lyu, Xueying;  Wang, Haitao; et al.
Favorite | TC[WOS]:11 TC[Scopus]:10  IF:8.2/8.3 | Submit date：2022/05/13
Anti-pd1/pd-l1 Therapy  Cholangiocarcinoma  Exhausted t Cells  Inflammatory Cytokines  Tumor Microenvironment  
Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites Journal article
Jing, Wanghui, Dong, Sijing, Luo, Xialin, Liu, Jingjing, Wei, Bin, Du, Wei, Yang, Lin, Luo, Hua, Wang, Yitao, Wang, Sicen, Lu, Haitao. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites[J]. Pharmacological Research, 2021, 164.
Authors:  Jing, Wanghui;  Dong, Sijing;  Luo, Xialin;  Liu, Jingjing;  Wei, Bin; et al.
Favorite | TC[WOS]:122 TC[Scopus]:133  IF:9.1/9.0 | Submit date：2021/09/13
Ahr Activation  Berberine  Gut Barrier Function  Inflammatory Bowel Disease  Microbial Tryptophan Catabolites  
Oxyphylla a promotes degradation of α-synuclein for neuroprotection via activation of immunoproteasome Journal article
Zhou,Hefeng, Li,Shengnan, Li,Chuwen, Yang,Xuanjun, Li,Haitao, Zhong,Hanbing, Lu,Jia Hong, Lee,Simon Ming Yuen. Oxyphylla a promotes degradation of α-synuclein for neuroprotection via activation of immunoproteasome[J]. Aging and Disease, 2020, 11(3), 559-574.
Authors:  Zhou,Hefeng;  Li,Shengnan;  Li,Chuwen;  Yang,Xuanjun;  Li,Haitao; et al.
Favorite | TC[WOS]:14 TC[Scopus]:17  IF:7.0/7.1 | Submit date：2021/03/01
Parkinson's Disease  Α-synuclein  Degradation  Proteasome  Neuroprotection  
Fish oil protects the blood-brain barrier integrity in a mouse model of Alzheimer's disease Journal article
Xie,Youna, Yan,Lingli, Zeng,Haitao, Chen,Weineng, Lu,Jia Hong, Wan,Jian Bo, Su,Huanxing, Yao,Xiaoli. Fish oil protects the blood-brain barrier integrity in a mouse model of Alzheimer's disease[J]. Chinese Medicine, 2020, 15(1), 29.
Authors:  Xie,Youna;  Yan,Lingli;  Zeng,Haitao;  Chen,Weineng;  Lu,Jia Hong; et al.
Favorite | TC[WOS]:14 TC[Scopus]:14  IF:5.3/5.5 | Submit date：2021/03/01
Amyloid Beta  Aβ-degrading Enzymes  Neuroinflammation  Nf-κb  Omega-3 Polyunsaturated Fatty Acids